Area of research
Surgery · Urology
Research interest
Research focused on Cystectomy and Peyronie's disease, with related work in Prostate cancer, Nephrology, Cystoprostatectomy. Notable publications include 'Tumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatment', 'Preoperative anemia is associated with adverse outcome in patients with urothelial carcinoma of the bladder following radical cystectomy', and 'The effect of intra- and postoperative allogenic blood transfusion on patients’ survival undergoing radical cystectomy for urothelial carcinoma of the bladder'.
The HELENA study: Hexvix®-TURB vs. white-light TURB followed by intravesical adjuvant chemotherapy—a prospective randomized controlled open-label multicenter non-inferiority study
Miniaturized percutaneous Nephrolithotomy without antibiotic prophylaxis: a single institution experience
Qualitätsparameter bei der radikalen Zystektomie – Chancen, Risiken, Herausforderungen
Blasenkarzinomsystemtherapie
Indikationen und Technik der Frühzystektomie
Ist die Fachrichtung assoziiert mit der Selbstsicherheit im Umgang mit rationaler Antibiotikaverordnung?
758P Assessment of prognostic and predictive value of FGFR alterations (FGFRa) in a real-world cohort of patients (pts) with high-risk pT1 non-muscle-invasive bladder cancer (NMIBC)
Correction to: The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence
Die DGU-Forschungsstipendien 2020
Prediction of early (30-day) and late (30–90-day) mortality after radical cystectomy in a comprehensive cancer centre over two decades
Sakrale Neuromodulation bei unter- und überaktivem Detrusor – quo vadis?
Prognostic role of FGFR Mutations and FGFR mRNA expression in metastatic urothelial cancer treated with anti-PD(L1) inhibitors in first and second-line setting
Efficacy of anti-PD(L)1 treatment in patients with metastatic urothelial cancer based on mRNA- and protein- based PD-L1 determination: Results from the multicentric, retrospective FOsMIC trial
Long-term outcome after grafting with small intestinal submucosa and collagen fleece in patients with Peyronie's disease: a matched pair analysis
Oncological outcomes of laparoscopic nephroureterectomy versus open radical nephroureterectomy for upper tract urothelial carcinoma: An European Association of Urology Guidelines systematic review
Die molekulare Charakterisierung des Peniskarzinoms
Bildgebung in der individualisierten Uroonkologie
Das Management von Patienten mit Peniskarzinom – Neue Aspekte in der Therapie einer seltenen Tumorentität
Wie werden der 10-Punkte-Plan des Deutschen Bundesministeriums für Gesundheit zur Bekämpfung resistenter Erreger und Maßnahmen des Antibiotic Stewardship wahrgenommen?
Wann ist die operative Versorgung von Metastasen beim Nierenzellkarzinom angezeigt und gibt es eine wissenschaftliche Grundlage hierfür?
Transurethrale Resektion der Blase
Tumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatment
Bicentric prospective evaluation of corporoplasty with porcine small intestinal submucosa (SIS) in patients with severe Peyronie’s disease
Is there evidence for a close connection between side of intravesical tumor location and ipsilateral lymphatic spread in lymph node-positive bladder cancer patients at radical cystectomy? Results of the PROMETRICS 2011 database
Preoperative anemia is associated with adverse outcome in patients with urothelial carcinoma of the bladder following radical cystectomy
The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence
Stoßwellenlithotripsie in Deutschland
Management of rectourinary fistula after urological interventions using biodesigned mesh: first experiences of an innovative technique
Das nicht-muskelinvasive High-grade-Harnblasenkarzinom
The effect of intra- and postoperative allogenic blood transfusion on patients’ survival undergoing radical cystectomy for urothelial carcinoma of the bladder